Systemic and Pulmonary Arterial Hypertension in Obstructive Sleep Apnea

Sleep Medicine Clinics

Volumn 2, Issue 4, 2007, Pages 549-557

  Becker, Heinrich F ^a,b   Javaheri, Shahrokh ^c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b ASKLEPIOS HOSPITAL BARMBEK   (Germany)

^c Sleepcare Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; OXYGEN;

AROUSAL; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; EFFECT SIZE; ENDOTHELIAL DYSFUNCTION; HEART CATHETERIZATION; HIGH RISK PATIENT; HUMAN; HYPERCAPNIA; HYPERTENSION; HYPOXIA; NONHUMAN; OXYGEN THERAPY; PATIENT COMPLIANCE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; RISK ASSESSMENT; SLEEP APNEA SYNDROME; SYMPATHETIC TONE; THORAX PRESSURE; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 65249158407     PISSN: 1556407X     EISSN: 15564088     Source Type: Journal    
DOI: 10.1016/j.jsmc.2007.07.010     Document Type: Review

References (57)

1. Coccagna G., Mantovani M., Brignani F., et al. Continuous recording of the pulmonary arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull Physiopathol Respir (Nancy) 8 5 (1972) 1159-1172
2. Young T., and Javaheri S. Systemic and pulmonary hypertension in obstructive sleep apnea. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and practices of sleep medicine. 4th edition (2005), WB Saunders, Philadelphia 1192-1202
3. Young T., Peppard P., Palta M., et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157 (1997) 1746-1752
4. Peppard P.E., Young T., Palta M., et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 19 (2000) 1378-1384
5. Bixler E.O., Vgontzas A.N., Lin H.M., et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 160 15 (2000) 2289-2295
6. Duran J., Esnaola S., Rubio R., et al. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 163 3 Pt 1 (2001) 685-689
7. Nieto F.J., Young T.B., Lind B.K., et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283 14 (2000) 1829-1836
8. Lavie P., Herer P., and Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 320 7233 (2000) 479-482
9. Grote L., Ploch T., Heitmann J., et al. Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Respir Crit Care Med 160 6 (1999) 1875-1882
10. Lavie P., Lavie L., and Herer P. All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J 25 3 (2005) 514-520
11. Somers V.K., Phil D., Dyken M.E., et al. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 328 5 (1993) 303-307
12. Hornyak M., Cejnar M., Elam M., et al. Sympathetic muscle nerve activity during sleep in man. Brain 114 (1991) 1281-1295
13. Mancia G. Autonomic modulation of the cardiovascular system during sleep. N Engl J Med 328 5 (1993) 347-349
14. Hedner J., Ejnell H., Sellgren J., et al. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension?. J Hypertens Suppl 6 (1988) S529-S531
15. Somers V.K., Dyken M.E., Clary M.P., et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96 4 (1995) 1897-1904
16. Carlson J.T., Hedner J., Elam M., et al. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 103 (1993) 1763-1768
17. Heitmann J., Ehlenz K., Penzel T., et al. Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 23 (2004) 255-262
18. Morgan B.J., Crabtree D.C., Palta M., et al. Combined hypoxia and hypercapnia evokes long-lasting sympathetic activation in humans. J Appl Physiol 79 (1995) 205-213
19. Xie A., Skatrud J.B., Crabtree D.C., et al. Neurocirculatory consequences of intermittent asphyxia in humans. J Appl Physiol 89 4 (2000) 1333-1339
20. Narkiewicz K., van de Borne P.J., Cooley R.L., et al. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98 8 (1998) 772-776
21. Brooks D., Horner R.L., Kozar L.F., et al. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99 1 (1997) 106-109
22. Ehlenz K. Regulation of blood volume-implications for cardiovascular pathophysiology in sleep apnoea. J Sleep Res 4 S1 (1995) 30-33
23. Krieger J., Follenius M., Sforza E., et al. Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea. Clin Sci (Lond) 80 5 (1991) 443-449
24. Lavie L. Sleep apnea syndrome, endothelial dysfunction, and cardiovascular morbidity. Sleep 27 (2004) 1053-1055
25. Ohike Y., Kozaki K., Iijima K., et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure-possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 69 2 (2005) 221-226
26. Grote L., Kraiczi H., and Hedner J. Reduced alpha- and beta(2)-adrenergic vascular response in patients with obstructive sleep apnea. Am J Respir Crit Care Med 162 4 Pt 1 (2000) 1480-1487
27. Kraiczi H., Hedner J., Peker Y., et al. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol 89 2 (2000) 493-498
28. Schulz R. The vascular micromilieu in obstructive sleep apnoea. Eur Respir J 25 (2005) 780-782
29. Schulz R., Schmidt D., Blum A., et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea-response to CPAP therapy. Thorax 55 (2000) 1046-1051
30. Engleman H.M., Gough K., Martin S.E., et al. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in "non- dippers". Sleep 19 (1996) 378-381
31. Monasterio C., Vidal S., Duran J., et al. Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 164 (2001) 939-943
32. Dimsdale J., Loredo J.S., and Profant J. Effect of continuous positive airway pressure on blood pressure. A placebo trial. Hypertension 35 (2000) 144-147
33. Barnes M., Houston D., Worsnop C.J., et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 165 (2002) 773-780
34. Barbé F., Mayorolas L.R., Duran J., et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. Ann Intern Med 134 (2001) 1015-1023
35. Faccenda J.F., Mackay T.W., Boon N.A., et al. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 163 (2001) 334-348
36. Norman D., Loredo J.S., Nelesen R.A., et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 47 5 (2006) 840-845
37. Pepperell J.C., Ramdassingh-Dow S., Crosthwaite N., et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359 (2002) 204-210
38. Mills P.J., Kennedy B.P., Loredo J.S., et al. Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. J Appl Physiol 100 1 (2006) 343-348
39. Becker H.F., Jerrentrup A., Ploch T., et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107 (2003) 68-73
40. Logan A.G., Tkacova R., Perlikowski S.M., et al. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 21 (2003) 241-247
41. Robinson G.V., Smith D.M., Langford B.A., et al. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 27 6 (2006) 1229-1235
42. In: Rich S. (Ed). Primary pulmonary hypertension: executive summary from the world symposium on primary pulmonary hypertension (1998), World Health Organization, Geneva (Switzerland)
43. Marrone O., and Bonsignore M.R. Pulmonary hemodynamics in obstructive sleep apnoea. Sleep Med Rev 6 (2002) 175-193
44. Tilkian A.G., Guillemina ult C., Schroeder J.S., et al. Hemodynamics in sleep-induced apnea. Studies during wakefulness and sleep. Ann Intern Med 85 (1976) 714-719
45. Chaouat A., Weitzenblum E., Krieger J., et al. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Chest 109 (1996) 380-386
46. Laks L., Lehrhaft B., Grunstein R.R., et al. Pulmonary hypertension in obstructive sleep apnea. Eur Respir J 8 (1995) 537-541
47. Sanner B.M., Doberauer C., Konermann M., et al. Pulmonary arterial hypertension in patients with obstructive sleep apnea syndrome. Arch Intern Med 157 (1997) 2483-2487
48. Arias M., Garcia-Rio F., Alonso-Fernandez A., et al. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure. Eur Respir J 27 (2006) 1106-1113
49. Bady E., Achkar A., Pascal S., et al. Pulmonary arterial hypertension in patients with sleep apnea syndrome. Thorax 55 (2000) 934-939
50. Hender J., Enjell H., and Caidahl K. Left ventricular hypetrophy independently of hypertension in patients with obstructive sleep apnea. J Hypertens 8 (1990) 941-946
51. Cargill J.L., Kiely D.G., and Lipworth B.J. Adverse effects of hypoxemia on diastolic filling in humans. Clin Sci 89 (1995) 165-169
52. Podszus T., Bauer W., Mayer J., et al. Sleep apnea and pulmonary hypertension. Kin Wochenschr 64 (1986) 131-134
53. Bradley T.D., Rutherford R., Grossman R.F., et al. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 131 (1985) 835-839
54. Motta J., Guilleminault C., Schroeder J.S., et al. Tracheostomy and hemodynamic changes in sleep-induced apnea. Ann Intern Med 89 (1978) 454-458
55. Alchanatis M., Tourkohoriti G., Kakouros S., et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea. Respiration 68 (2001) 566-572
56. Sajkov D., Wang T., Saunders N.A., et al. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 165 (2002) 152-158
57. Sforza E., Krieger J., Weitzenblum E., et al. Long-term effects of treatment with nasal continuous positive airway pressure on daytime lung function and pulmonary hemodynamics in patients with obstructive sleep apnea. Am Rev Respir Dis 141 (1990) 866-870